Collin M. Todd
Senior Vice President, Strategy and Business Development · Odyssey Therapeutics, Inc.
Individual
- 2026
- May 12, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Collin M. Todd files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- TPG GP A, LLC - $25.00M in ODTX purchases and sales in the last 12 months
- Nan (Ln) Li - $20.00M in ODTX purchases and sales in the last 12 months
- Dimension Capital II, L.P. - $20.00M in ODTX purchases and sales in the last 12 months
- SR ONE CAPITAL MANAGEMENT, LLC - $10.03M in ODTX purchases and sales in the last 12 months
- Shelley Chu - $200K in ODTX purchases and sales in the last 12 months
- Jeffrey M. Leiden - $100K in ODTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Collin M. Todd?
Collin M. Todd is a corporate insider, tracked as Senior Vice President, Strategy and Business Development of Odyssey Therapeutics, Inc. (ODTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Collin M. Todd last file a Form 4?
The only primary Form 4 on record is dated 12 May 2026.